DiaFree Juice effective in reducing Fasting Blood Sugar (FBS) and Post-Prandial Blood Sugar (PPBS) values by up to 30% within 3 months of consumption
Kapiva, a Mumbai-based ayurveda brand, recently conducted an AYUSH-approved single-arm, open-label clinical trial to prove the efficacy of Kapiva Dia-free Juice in the management of Diabetes Mellitus and improving the quality of life.
Made with ayurvedic herbs like Amla, Karela, Jamun, Giloy, Neem, Methi Gudmar, and others, the juice is found to be effective in lowering Fasting Blood Sugar (FBS) and Post-Prandial Blood Sugar (PPBS) value up to 30%. It has also proven to be effective in decreasing HbA1c to an extent of 11% and increasing insulin production in the body by up to 25-30%.
This study was conducted in compliance with the approved protocol, and requirements of the Indian Council of Medical Research (ICMR) ethical guidelines, GCP (Good clinical practices), and schedule Y. The study was conducted over a period of 3 months and changes in the diabetic panel, i.e., glycosylated haemoglobin (HbA1C), fasting blood sugar, and postprandial blood sugar (after a meal) were measured. In order to evaluate improvement in quality of life, reduction in Body mass index (BMI) and any notable changes in haematology and biochemistry profile were also measured.
Dr Rajendra Sharma, Principal Investigator of the trial, said “Based on the lab reports & patient feedback on the quality of life, the Kapiva Dia-free juice was found to be effective and safe. The juice was safe for use in the recommended dosage. It helps in reducing the fasting blood sugar, post-prandial blood sugar, controlling HbA1C values.”